Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.

ABSTRACT:

SUBMITTER: Sodhi M 

PROVIDER: S-EPMC10557026 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature